Physician profile
Mark I Rubinstein
NPI 1003871971
$2,060.52
in general payments reported to CMS, 2019-2025
15 companies · $805 in 2025
The $805 reported for 2025 was more than what 75% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $306 · 2020: $17.21 · 2021: $185 · 2022: $170 · 2023: $274 · 2024: $303 · 2025: $805.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,135 · Long Term Medical Supply Or Device Loan: $248.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,134.51 |
| Long Term Medical Supply Or Device Loan | $247.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $478.84 | 2024-2025 | Integra, Inspira Air, Acclarent Aera |
| Medtronic, INC. | $331.51 | 2024-2025 | Pteye Parathyroid Detection System, Propel |
| Acclarent, INC | $206.24 | 2019-2023 | Trudi Nav Cable, Relieva Spinplus |
| Galderma Laboratories, L.P. | $180.78 | 2019-2024 | |
| Genzyme Corporation | $167.34 | 2021-2025 | |
| Glaxosmithkline, LLC. | $141.65 | 2023-2025 | Nucala |
| Medtronic USA, INC. | $128.63 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $118.30 | 2022 | |
| Stryker Corporation | $86.15 | 2021-2025 | Audion Et Dilation System |
| Allergan, INC. | $60.90 | 2019-2021 | |
| Aerin Medical INC. | $47.33 | 2024 | |
| Solta Medical, A Division of Bausch Health US, LLC | $37.46 | 2024-2025 | |
| Kaleo, INC. | $34.71 | 2019-2024 | Auvi-Q |
| Merck Sharp & Dohme LLC | $24.92 | 2025 | Keytruda |
| Alk-Abello, INC | $15.76 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Rubinstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.